1. Home
  2. ALM vs OCS Comparison

ALM vs OCS Comparison

Compare ALM & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ALM

Almonty Industries Inc.

HOLD

Current Price

$14.05

Market Cap

1.5B

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$24.42

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALM
OCS
Founded
N/A
2003
Country
Canada
Switzerland
Employees
N/A
3
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALM
OCS
Price
$14.05
$24.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$22.33
$42.00
AVG Volume (30 Days)
6.2M
352.6K
Earning Date
03-18-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$583.67
$466.06
Revenue Next Year
$90.33
$502.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$14.00
52 Week High
$22.55
$30.68

Technical Indicators

Market Signals
Indicator
ALM
OCS
Relative Strength Index (RSI) 40.12 40.05
Support Level $5.32 $19.00
Resistance Level $14.92 $29.19
Average True Range (ATR) 1.62 1.25
MACD -0.78 -0.20
Stochastic Oscillator 1.06 17.11

Price Performance

Historical Comparison
ALM
OCS

About ALM Almonty Industries Inc.

Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: